Tori Whitacre Martonicz

Two unsettling zoonotic developments are testing the limits of infection prevention and public health vigilance in the US. In Washington State, a resident has tested preliminarily positive for avian influenza, marking the first human case in 9 months. Meanwhile, in New Jersey, researchers have documented the nation’s first fatality linked to alpha-gal syndrome, which is a tick-borne meat allergy caused by the bite of the lone star tick.

The November/December 2025 issue of Infection Control Today® dives into overlooked risks, breakthrough technologies, and the people driving innovation across IPC, EVS, and sterile processing. From bacteriophage therapy to burnout prevention, automation to UV regulation—it’s a powerful close to the year. Read the issue now: https://www.infectioncontroltoday.com/journals/infection-control-today #InfectionPrevention #Healthcare #InfectionControl #EVS #IPC #PatientSafety #ICT

After nearly a decade of research and regulatory review, the US Environmental Protection Agency (EPA) has determined that Micrillon, a polymer-based antimicrobial additive developed by UMF Corporation, is not a pesticide—clearing the way for new infection prevention applications. In this interview, UMF President George Clarke and Editorial Advisory Board member Heather Stoltzfus, MPH, RN, CIC, discussed how this rechargeable technology could redefine cleaning, sustainability, and surface safety across healthcare and hospitality settings.

Conversations about HIV and sexual health can still feel uncomfortable, but they don’t have to. In a candid interview, Hope & Help medical director Cariane Morales Matos, MD, explains why open, stigma-free discussions about HIV prevention and PrEP are essential for protecting teens, families, and communities.

I’ve known Monica and Tim forever, which is why their sepsis battles aren’t just “patient stories” to me. They’re a reminder that infection hides in ordinary days, and that vigilance, source control, and smart antibiotics save lives.

Infection prevention may be built on evidence, but it thrives on empathy. During a recent Infection Control Today roundtable, in this third installment, veteran infection preventionists shared how emotional intelligence, communication, and systems thinking—not just clinical expertise—define the profession’s future.

In a postpandemic health system, infection preventionists are hired for certifications but kept for soft skills. In this second installment of ICT's roundtable, veteran IPs chart the shift from task-doer to systems leader, calling for smarter staffing, structured onboarding, and relationship-first programs to beat burnout and turnover.

Infection prevention’s future will be won with mentorship, soft skills, and honest collaboration—not just guidelines. In a candid roundtable, veteran IPs shared how to steady first-year practitioners: pair them with real mentors, teach time management and tough conversations, and build cultures that value “let me confirm” over guesswork.

When a nationwide blood-culture bottle shortage squeezed hospitals, a Stanford-led team turned to machine learning by building and openly sharing tools that predict which patients are most likely to have bacteremia and when a culture can be safely deferred. The simplest version works as a quick bedside score, no new software required.

A Bangladesh research team unveiled a suitcase-sized, point-of-care test that detects Nipah virus from respiratory patients in about 30 minutes, showing accuracy comparable to RT-PCR, and designed to bring rapid diagnosis and outbreak control to rural, low-resource settings.

From hand-hygiene audits to the SHEA Board of Trustees, the professional path of Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, traces the arc of modern infection prevention. The former hospital IP—now a University of Pittsburgh assistant professor—pairs frontline experience with genomic epidemiology to turn sequencing into outbreak-stopping action.

When Hurricane Helene flooded a North Carolina facility and sparked an IV fluid shortage, Duke’s stewardship network turned crisis into practice change—rapidly shifting eligible patients to highly bioavailable oral antibiotics and boosting PO use by 5.6% across participating hospitals.

At IDWeek in Atlanta, former CDC director Tom Frieden unveiled a crisp playbook for infection prevention—“See. Believe. Create.”—arguing it can help hospitals spot outbreaks sooner, reverse drug resistance, and drive HAIs toward zero. He paired the message with a 7-1-7 target: 7 days to find an outbreak, 1 to report, 7 to control.

What do schools need to prevent the spread of infectious diseases? Infection prevention experts and school staff in Nebraska present their collaboration at IDWeek2025.

California’s first locally acquired dengue case in 2023 triggered a rapid serosurveillance effort across Southern California—and IDWeek 2025 results suggest infections are underrecognized, with DENV-3 detected and widespread flavivirus cross-reactivity from West Nile virus complicating diagnosis.

Could Dollar General be Alabama’s next vaccination hub? At IDWeek 2025, John R. Bassler, MS, and colleagues showed that strategically pairing mobile clinics with DG stores could help close stubborn geographic vaccine gaps, especially in counties with higher social deprivation where traditional providers are scarce.

Hospital-wide sequencing of 8,567 Staphylococcus aureus isolates at NYU Langone revealed that many MRSA cases stem from tight community transmission networks—not in-hospital spread. Presented at IDWeek 2025, the work pinpoints distinct clusters (young MSM/substance-use networks, long-term care residents, and children) and urges IPC strategies that bridge hospital and community.

At IDWeek 2025, a Detroit consortium reported a familiar IPC paradox in skilled nursing facilities: Staff know the basics, but practice lags. Inconsistent rub times, dwell times, and respirator seal checks point to behavior-focused training—not more slides—as the next move.

A multifaceted infection-prevention push at a tertiary rehab ICU in the Upper Midwest reversed a rise in C difficile, lifting hand-hygiene adherence from 69% to 91% and cutting the C. diff standardized infection ratio from 1.6 to 0.4 over six months, researchers reported at IDWeek 2025 in Atlanta.

New IDWeek 2025 data show who C difficile kills most: White patients, women, and people in major metros—with most deaths tied to health care exposure—underscoring how basics and smarter antibiotics remain our best levers to cut mortality.